Balancing Bleeding and Thrombosis in Lung Adenocarcinoma – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Thomas Fusillo et al. published in JTH, adding:
“Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and VEGF or EGFR inhibitors
Clinicians often worry about combining anticoagulation with targeted cancer drugs.
In patients with lung adenocarcinoma, giving anticoagulants alongside VEGF or EGFR inhibitors was not associated with a statistically significant rise in major or clinically relevant non-major bleeding.
The data offer some reassurance for treating thrombosis in this group, though careful patient selection still applies.”
Title: Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors
Authors: Thomas F. Fusillo, Avi Leader, Simon Mantha, Helen Ajufo, Andriy Derkach, Adam Schoenfeld, Rohan Singh, Peter Kaplinsky, Jeffrey I. Zwicker
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit
-
Jul 20, 2026, 21:15Leonie Bolt: Honored to Present on Coronary Artery Calcium Scoring in Hemophilia A at ISTH 2026
-
Jul 20, 2026, 21:12Mihir Jain: Can Gene Therapy Transform Hemophilia Care in India?
-
Jul 20, 2026, 21:10Mohammed W. Badri: Are We Doing Enough to Prevent Life-Threatening Bleeds in Children?
-
Jul 20, 2026, 19:56Asima Ahmad: Decoding Heavy Bleeding – What Your Symptoms Could Be Telling You
-
Jul 20, 2026, 19:41Athma Dias: The Diagnostic Challenge of Inherited Platelet Function Disorders
-
Jul 20, 2026, 19:21Salwa Almefareh: Bringing Life-Changing Haemophilia Care to Patients Worldwide
-
Jul 20, 2026, 19:06Sam Hirniak: Symptoms, Diagnosis, and Treatment for Women and Girls with Hemophilia
-
Jul 20, 2026, 18:29Masoabi Sefojane: Every Leadership Journey has it’s Season